Literature DB >> 21112562

MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states.

Pierre Neveu1, Min Jeong Kye, Shuping Qi, David E Buchholz, Dennis O Clegg, Mustafa Sahin, In-Hyun Park, Kwang-Soo Kim, George Q Daley, Harley I Kornblum, Boris I Shraiman, Kenneth S Kosik.   

Abstract

Reprogramming methodologies have provided multiple routes for achieving pluripotency. However, pluripotency is generally considered to be an almost singular state, with subtle differences described between induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). We profiled miRNA expression levels across 49 human cell lines, including ESCs, iPSCs, differentiated cells, and cancer cell lines. We found that the resulting miRNA profiles divided the iPSCs and hESCs examined into two distinct categories irrespective of the cell line origin. The miRNAs that defined these two pluripotency categories also distinguished cancer cells from differentiated cells. Transcriptome analysis suggested that several gene sets related to p53 distinguished these categories, and overexpression of the p53-targeting miRNAs miR-92 and miR-141 in iPSCs was sufficient to change their classification status. Thus, our results suggest a subdivision of pluripotent stem cell states that is independent of their origin but related to p53 network status.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112562     DOI: 10.1016/j.stem.2010.11.012

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  56 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 2.  Mechanisms of age-related cognitive change and targets for intervention: epigenetics.

Authors:  Kenneth S Kosik; Peter R Rapp; Naftali Raz; Scott A Small; J David Sweatt; Li-Huei Tsai
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-20       Impact factor: 6.053

Review 3.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

Review 4.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

5.  Reprogramming somatic cells to pluripotency: a fresh look at Yamanaka's model.

Authors:  Yangxin Li; Zhenya Shen; Harnath Shelat; Yong-Jian Geng
Journal:  Cell Cycle       Date:  2013-10-25       Impact factor: 4.534

Review 6.  Progress in understanding reprogramming to the induced pluripotent state.

Authors:  Kathrin Plath; William E Lowry
Journal:  Nat Rev Genet       Date:  2011-04       Impact factor: 53.242

Review 7.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

8.  MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact.

Authors:  Tian Wang; San-bao Shi; Hong-ying Sha
Journal:  RNA Biol       Date:  2013-07-23       Impact factor: 4.652

9.  Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.

Authors:  Izumi Horikawa; Kye-Yoon Park; Kazunobu Isogaya; Yukiharu Hiyoshi; Han Li; Katsuhiro Anami; Ana I Robles; Abdul M Mondal; Kaori Fujita; Manuel Serrano; Curtis C Harris
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

10.  Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.

Authors:  Anastasia Petrova; Antonio Capalbo; Laureen Jacquet; Simon Hazelwood-Smith; Dimitra Dafou; Carl Hobbs; Matthew Arno; Alessio Farcomeni; Liani Devito; Heba Badraiq; Michael Simpson; John A McGrath; Wei-Li Di; Jeffrey B Cheng; Theodora M Mauro; Dusko Ilic
Journal:  Stem Cells Dev       Date:  2016-08-30       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.